Clinical Trial Update: A Study of MDX-1106 to Treat Patients With Hepatitis C Infection [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating MDX-1106 for hepatitis C has completed, according to the trial record sponsored by Bristol-Myers Squibb.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• MDX-1106

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED